Fertility and sterility
Fertility and sterility
Audio Summaries
Every issue of Fertility and sterility moves the field forward, but reading every paper cover-to-cover isn't realistic. OSLR turns each article into a 3-minute audio summary so you can stay current while you commute, round, or work out.
Recent summaries
The latest articles summarized from Fertility and sterility.
Endometrial fertility. Management of adenomyosis in gynecology and infertility.
Nov 19, 2026
This review examines how adenomyosis should be managed in gynecology and infertility, focusing on its diagnosis via MUSA criteria, its link to endometriosis, and the limited options for women trying to conceive. The authors ask whether surgery, hormonal therapy, or IVF (with or without pretreatment such as GnRH agonists, dienogest, or levonorgestrel-releasing intrauterine systems) can improve fertility outcomes. They conclude that current evidence is insufficient and inconsistent, with possible reduced live birth rates after IVF, and call for standardized prospective studies and randomized controlled trials.
Robotic-Assisted Uterus Transplantation: A Cadaveric Feasibility Model.
Nov 16, 2026
This cadaveric study asked whether uterine graft implantation can be performed robotically, given that recipient surgery for uterus transplantation remains predominantly open while donor hysterectomy has already moved to robotic platforms. Using a da Vinci system in a 67-year-old female cadaver with a graft from a 50-year-old brain-dead donor, the authors performed six end-to-side vascular anastomoses to the external iliac vessels and a vaginal anastomosis, completing the procedure in 156 minutes of console time with no revisions needed and all anastomoses confirmed patent. The authors conclude that robotic-assisted uterus implantation is technically feasible in this model, supporting further preclinical and clinical evaluation of a minimally invasive approach.
The challenge of Adenomyosis across the ART journey: insights from the Naples Workshop group.
Nov 15, 2026
This narrative review, informed by the 2025 Naples Workshop, asks how adenomyosis should be managed across the assisted reproductive technology (ART) pathway, from pre-treatment diagnosis and ovarian reserve assessment, through embryo transfer strategies, to pregnancy, delivery, and postpartum care. The authors synthesize existing evidence and multidisciplinary clinical expertise to offer practical considerations while highlighting areas of uncertainty. They conclude that management should be individualized based on phenotype, symptoms, reproductive goals, and ART history, and that many commonly proposed interventions still need confirmation in well-designed prospective studies.
VIEWS AND REVIEWS DIFFUSE ADENOMYOSIS PRIOR TO FROZEN EMBRYO TRANSFER: CLINICAL RELEVANCE, DIAGNOSIS AND TREATMENT.
Nov 13, 2026
This review examines diffuse adenomyosis in reproductive-aged women undergoing assisted reproduction, tracing its historical recognition, epidemiology, and impact on IVF outcomes. The authors ask whether optimizing the uterine environment before frozen embryo transfer is biologically justified, concluding that adenomyosis is linked to lower pregnancy and live birth rates and higher miscarriage risk, with effects tied to severity and phenotype. They note that no single pretreatment strategy is yet supported by evidence, and they introduce a planned series of papers on its pathophysiology, diagnosis, and treatment before FET.
Chronic Endometritis: Does the Current Evidence Justify Routine Diagnosis and Treatment?
Nov 13, 2026
This review asks whether chronic endometritis, defined by endometrial CD138-positive plasma cells, is a clinically meaningful condition that justifies routine screening and antibiotic treatment in reproductive medicine. The authors conclude that it does not: diagnostic criteria are unvalidated, CD138-positive cells fluctuate across the menstrual cycle and appear in fertile women, and while antibiotics reduce CD138 positivity, controlled studies show no improvement in reproductive outcomes. Until biological validity and clinical benefit are demonstrated, they argue routine CE screening and treatment cannot be justified.
Different strategies for medical management before frozen embryo transfer in patients with adenomyosis.
Nov 12, 2026
This narrative review asks whether medical pretreatment before frozen embryo transfer (FET) improves live birth rates in women with adenomyosis, and which strategies (GnRH agonist, aromatase inhibitors, letrozole, progestins, or oral GnRH antagonists) hold the most promise. The authors found that GnRH agonist pretreatment did not improve live birth in FET meta-analyses or in the one randomized trial, and the overall certainty of evidence is low. They suggest that pooling heterogeneous adenomyosis phenotypes may mask benefit in selected women, such as those with junctional-zone involvement, and call for randomized trials stratified by standardized phenotype.
In Vitro Fertilization versus Intrauterine Insemination for Cumulative Live Birth and Cost-Effectiveness in Older Low-Prognosis Women with Diminished Ovarian Reserve.
Nov 11, 2026
This retrospective cohort study compared initial IVF with up to three IUI cycles for cumulative live birth and cost-effectiveness in older women (35-50 years) with diminished ovarian reserve classified as POSEIDON group 4. IVF yielded a substantially higher cumulative live birth rate (21.9% vs. 7.6%) but cost about 5.7 times more per patient (21,588 vs. 3,802 yuan), with cost-effectiveness depending on willingness-to-pay thresholds and becoming less favorable at older ages. A third IUI cycle added minimal benefit (0.11 percentage points), suggesting treatment choices should weigh prognosis, prior treatment, and patient preferences.
State of the Reproductive Urology Workforce: Trends and Geographic Distribution of Reproductive Urologists from 2005 to 2024.
Nov 10, 2026
This cross-sectional study mapped the geographic distribution of reproductive urologists (RUs) across the US from 2005 to 2024 to assess whether access to male infertility care has kept pace with workforce shortages and rising assisted reproductive technology (ART) use. The authors found 228 RUs in 2024 (up 15.7% since 2005), but only 68.9% of US males aged 20–49 lived within 60 miles of one, 13 states still had no RUs, and IVF cycles per RU rose 2.8-fold. They conclude that significant "care deserts" persist and call for targeted interventions in unserved states and high-IVF-volume areas.
Association between non-invasive PGT-A (niPGT-A) and live birth using spent embryo culture medium in donor oocyte cycles: a prospective non-selection cohort study.
Nov 10, 2026
This prospective, blinded cohort study asked whether aneuploidy testing of spent embryo culture medium (niPGT-A), run without influencing embryo selection, is associated with live birth in donor-oocyte recipients undergoing their first fresh blastocyst transfer. Among 135 informative transfers, live birth occurred in 56.0% of euploid-classified embryos versus 36.7% of aneuploid-classified embryos (adjusted OR about 0.45-0.50, depending on morphology grading system), but niPGT-A added little prognostic discrimination beyond morphology and clinical variables. The authors conclude that niPGT-A shows an association with live birth, but its diagnostic accuracy and clinical utility remain to be established.
Transrectal approach to oocyte retrieval in a patient with vaginal cancer.
Oct 30, 2026
This video article describes transrectal ultrasound-guided oocyte retrieval (TROR) as a fertility preservation option for a 19-year-old virginal patient with vaginal clear cell cancer who could not tolerate transvaginal or pelvic examination. The authors asked whether TROR could be safely planned and performed when standard approaches were limited, and the procedure yielded 29 oocytes, 28 of which were mature and cryopreserved, with an uneventful recovery. They conclude that TROR is a viable alternative to transabdominal or laparoscopic retrieval in patients with vaginal or cervical cancer, though it should be reserved for cases where other approaches are unsafe or infeasible.
